New drug M7437 targets Hard-to-Treat cancers in early trial
NCT ID NCT07360314
First seen Jan 23, 2026 · Last updated May 16, 2026 · Updated 22 times
Summary
This early-stage study tests a new drug called M7437 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to deliver a cancer-killing agent directly to tumor cells. The main goals are to check safety and find the right dose, while also looking for signs that the tumors shrink.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer - Vancouver - BC Cancer Agency
NOT_YET_RECRUITINGVancouver, Canada
Contact Phone: •••-•••-••••
Contact
-
Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center
NOT_YET_RECRUITINGHuntersville, North Carolina, 28078, United States
Contact Phone: •••-•••-••••
Contact
-
Hospital Universitari Vall d'Hebron - VHIO - Oncology - Phase I Unit
NOT_YET_RECRUITINGBarcelona, 08035, Spain
Contact
-
NEXT Houston
RECRUITINGGalveston, Texas, 77001, United States
Contact
-
NEXT Madrid - Hospital Universitario Quironsalud Madrid
NOT_YET_RECRUITINGMadrid, Spain
Contact Phone: •••-•••-••••
Contact
-
NEXT Oncology - PARENT
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Phone: •••-•••-••••
Contact
-
National Cancer Center Hospital
RECRUITINGTokyo, Japan
Contact Phone: •••-•••-••••
Contact
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Canada
Contact Phone: •••-•••-••••
Contact
-
Yale University - Yale University School of Medicine
NOT_YET_RECRUITINGNew Haven, Connecticut, 06510, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.